Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease

Author： Ibrahim Basma M Tsifansky Michael D Yang Yan Yeo Yoon

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.8, Iss.4, 2011-04, pp. : 451-466

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Screening for Cystic Fibrosis

By Cuckle H. Murray J.

Disease Management & Health Outcomes, Vol. 3, Iss. 4, 1998-04 ,pp. : 161-172

Adis International

Access to resources Recommend Favorite

Cystic fibrosis (CF)

International Journal of Child and Adolescent Health, Vol. , Iss. , 2017-01 ,pp. : 115-115

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Advances and challenges of nanotechnology-based drug delivery systems

By Jiang Wen Kim Betty YS Rutka James T Chan Warren CW

Expert Opinion on Drug Delivery, Vol. 4, Iss. 6, 2007-11 ,pp. : 621-633

Informa Healthcare

Access to resources Recommend Favorite

Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs

By Lacko Andras G Nair Maya Prokai Laszlo McConathy Walter J

Expert Opinion on Drug Delivery, Vol. 4, Iss. 6, 2007-11 ,pp. : 665-675

Informa Healthcare

Access to resources Recommend Favorite

The adaptations of a quality of life questionnaire for routine use in clinical practice: the Chronic Respiratory Disease Questionnaire in cystic fibrosis

By Bradley J. Dempster M. Wallace E. Elborn S.

Quality of Life Research, Vol. 8, Iss. 1-2, 1999-01 ,pp. : 65-71

Springer Publishing Company

Access to resources Recommend Favorite